NCT00271453View on ClinicalTrials.gov

A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 29, 1996

Study Completion Date

October 31, 1998

Conditions
Chronic Pain
Interventions
DRUG

Durogesic® (fentanyl transdermal drug delivery system)

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00271453 - A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy | Biotech Hunter | Biotech Hunter